Normosang Orphan Europe Uses, Dosage, Side Effects and more
Normosang Orphan Europe (trade name Panhematin) is an iron-containing porphyrin. More specifically, it is protoporphyrin IX containing a ferric iron ion (heme B) with a chloride ligand.
| Trade Name | Normosang Orphan Europe |
| Availability | Prescription only |
| Generic | Hemin |
| Hemin Other Names | chloro(protoporphyrinato)iron(III), Hämin, Hemina, hémine, protohemin |
| Related Drugs | chlorpromazine, Thorazine, Givlaari, givosiran, Panhematin |
| Type | |
| Groups | Approved, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Taiwan |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Normosang Orphan Europe is an iron-containing porphyrin injection used for the relief of recurrent attacks of acute intermittent porphyria (AIP) associated with the menstrual cycle when carbohydrate therapy is not effective.
Used in the management of porphyria attacks, particularly in acute intermittent porphyria.
Normosang Orphan Europe is also used to associated treatment for these conditions: Coproporphyria, Hereditary, Porphyrias, Acute, Variegate Porphyria
Food Interaction
No interactions found.Drug Interaction
Moderate: clopidogrel, clopidogrelUnknown: buspirone, buspirone, docusate, docusate, metoprolol, metoprolol, mirtazapine, mirtazapine, acetaminophen, acetaminophen, albuterol, albuterol, sertraline, sertraline
